Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06247124 · ClinicalTrials.gov registry record · NA

OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama

A NA study of HPV Vaccination, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT06247124 is a NA study of HPV Vaccination that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 29 participants, below the 680-participant average among 4 other HPV Vaccination trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06247124, a NA study of HPV Vaccination, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination for all children and adults ages 9 to 26 in the U.S. However, HPV vaccination rates nationally and in Alabama lag far behind the Healthy People 2020 goal of 80% coverage. Despite multiple efforts, Alabama still ranks third in cervical cancer mortality and incidence nationally with great disparities within the state, particularly between urban and rural counties. In order to address this public health challenge, organizations have come together to develop, implement, and evaluate a statewide action plan to eliminate cervical cancer as a public health problem in Alabama by 2033. This plan was officially launched by the State Health Officer in May 2023 as a partnership between government, academia, civic organizations, and non-profit organizations and is known as OPERATION WIPE OUT. The overall goal of this Supplement is to develop, implement, and examine the feasibility and scalability of a theory-driven, participatory multi-channel communication campaign to promote HPV vaccination uptake that is designed and delivered by high school students with the support of OPERATION WIPE OUT partners and linked to school-based vaccination in a rural county that has the highest cervical cancer incidence in the state (Chambers County). The specific aims are: (1) To develop and examine the feasibility of a theory-driven, participatory multi-channel communication campaign to promote HPV vaccination uptake with high school students being agents of change and provision of school-based vaccination; and (2) To examine specific features of the multi-channel communication campaign regarding scalability, sustainability, and potentially a future full-scale implementation science trial. The primary outcome will be HPV vaccination uptake at the county level obtained Alabama Department of Public Health Vaccination Registry (ImmPRINT). Additionally, treatment fidelity and scalability assessments will be conducted

Conditions Studied

Interventions

  • BEHAVIORAL multi-channel communication campaign to promote HPV vaccination

Study Locations (1)

Alabama

  • Chambers County School District - Lafayette

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2023-11-01
Est. Completion 2026-03-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06247124

The ClinicalTrials.gov registry entry for NCT06247124 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 680-participant average among 4 other HPV Vaccination trials with a reported enrollment target (96% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HPV Vaccination appearing as the primary indexed condition, and to 1 intervention - of which multi-channel communication campaign to promote HPV vaccination is the first listed.

NCT06247124 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06247124 about?

NCT06247124 is a clinical study titled "OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama". The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination for all children and adults ages 9 to 26 in the U.S. However, HPV vaccination rates nationally and in Alabama lag far behind the Healthy People 2020 goal of 80% coverage. Despite multiple efforts, Alabama still ranks ...

What is the current status of trial NCT06247124?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 29 participants. The study started on 2023-11-01. Estimated completion is 2026-03-31.

What conditions does trial NCT06247124 study?

This clinical trial studies the following conditions: HPV Vaccination.

What interventions are being tested in trial NCT06247124?

The interventions under investigation include: multi-channel communication campaign to promote HPV vaccination (BEHAVIORAL).

Who is sponsoring clinical trial NCT06247124?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06247124 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HPV Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.